Fractional CO2 laser for chronic Peyronie's disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 1 interventional study at The Ottawa Hospital compares fractional CO2 laser treatment to a sham (no treatment) control in men with chronic Peyronie's disease. Eligible participants have had PD for at least 12 months with a stable single-plane penile curvature of 30°–90° and are able to complete validated PD questionnaires in English. Treatment is delivered to the penile plaque with follow-up visits to measure curvature, collect patient-reported outcomes, and monitor safety. The primary focus of this early-phase trial is safety and tolerability, with preliminary signals of symptom or curvature change recorded.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Men 18 or older. For heterosexual men it is required they be in a stable relationship with a female spouse/partner for at least 3 months and willing to have vaginal intercourse for purposes of properly filling out the validated PD Questionnaire.
2. Diagnosis of PD for at least 12 months with evidence of stable disease as determined by the investigator (i.e. no change in penile curve for at least 6 months and absence of pain).
3. Penile curvature of 30º-90º in the dorsal, lateral, or dorsal/lateral plane (must be possible to delineate the single plane of maximal curvature for evaluation)
4. Signed informed REB-approved consent agreement; signed authorization form to allow disclosure of protected information.
5. Ability to read, complete, and understand the various rating instruments in English.

Exclusion Criteria:

1. Penile curvature of \<30º or \>90º
2. Any conditions affecting the penis such as a chordee in the presence or absence of hypospadias; thrombosis of the dorsal penile artery; infiltration by a benign or malignant mass or an infectious agent; ventral curvature from any cause; presence of an active sexually transmitted disease.
3. Failure to achieve a sufficient 8/10 erection (after prostaglandin E or Trimix administration), in the opinion of the investigator, to accurately measure the penile deformity.
4. Calcified plaque as evident by appropriate radiographic evaluation, i.e., penile ultrasound that would prevent treatment with Fractional CO2 Laser
5. Isolated hourglass deformity of the penis without curvature
6. Treatment or plans to undergo treatment for PD, including but not limited to any previous surgery, oral/topical agents within 3 months, intralesional medical therapies within 3 months, extracorporeal shock wave therapy within 6 months, or use of mechanical devices within 2 weeks before the start of the study

Where it's running

• The Ottawa Hospital
  Ottawa, Ontario, Canada Recruiting

Study contacts

• Principal investigator: Luke Witherspoon — Ottawa Hospital Research Institute
• Study coordinator: Amanda Ross
• Email: amanross@toh.ca
• Phone: 6137985555

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Can FAPI or FDG PET/CT help diagnose active Peyronie's disease

  This study tests whether FAPI-PET/CT or FDG-PET/CT scans can detect active inflammation or fibroblast activity in men with Peyronie’s disease.

  Recruiting Phase 4 University Medical Center Groningen · Nieuwegein, Utrecht · NCT07903987

• Platelet-rich plasma injections for Peyronie's disease

  This will test whether injections of a man's own platelet-rich plasma can reduce penile curvature and plaque in men with stable (fibrotic phase) Peyronie's disease.

  Recruiting Herlev Hospital · Herlev · NCT07117955

• One-time Pain Reprocessing Therapy session for chronic pain at The Ottawa Hospital

  A single four-hour session of Pain Reprocessing Therapy is being tested to see if it can help adults with chronic pain feel better and have less pain.

  Recruiting Ottawa Hospital Research Institute · Ottawa, Ontario · NCT07919626

• Blood Transfusion Thresholds During Major Surgery

  This study tests whether a higher versus lower blood transfusion threshold during surgery helps reduce serious complications or death after major surgery.

  Recruiting Ottawa Hospital Research Institute · Ottawa, Ontario and 1 other locations · NCT07748663

• Brain scans to find links between brain activity and knee replacement outcomes

  This study uses brain MRI before and after knee replacement to see if patterns of brain activity can predict which patients will be satisfied with their surgery.

  Recruiting Ottawa Hospital Research Institute · Ottawa, Ontario · NCT07464080

• Safety of perioperative blood thinner management in people with cancer undergoing surgery or procedures

  This study tests how safe current practices are for stopping or continuing blood thinners in adults with cancer who are having surgery or procedures, to see if bleeding or clots are affected.

  Recruiting Ottawa Hospital Research Institute · Ottawa · NCT07372716

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.